Business Context and Reporting Period
This Form 6-K filing by Moolec Science SA (NASDAQ: MLEC) covers the month of December 2025. The registrant is a Cayman Islands-incorporated company. The primary purpose of this report is to announce the adjournment of its Extraordinary General Meeting of Shareholders (EGM).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial performance data.
Material Changes and Corporate Actions
- Meeting Adjournment: The EGM scheduled for December 12, 2025, was adjourned to December 16, 2025, at 9:00 a.m. Eastern Time due to a lack of quorum.
- Voting Statistics: A total of 4,339,915 ordinary shares were voted out of 10,891,761 shares entitled to vote, representing 39.846% of the voting power.
- Quorum Rules: If a quorum is not present at the adjourned meeting, any number of shareholders present in person or by proxy will constitute a quorum.
- Proxy Validity: Proxy cards delivered for the original EGM will be voted at the adjourned meeting.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the company's performance, prospects, and revenues. Management cautions that these statements are based on current expectations and are subject to significant risks and uncertainties, including those detailed in the company's Annual Report on Form 20-F. No specific operational guidance or new risk factors were introduced in this document.
Investor Verification Checklist
- Verify the outcome of the adjourned EGM scheduled for December 16, 2025.
- Confirm the specific matters proposed for shareholder approval at the EGM, which are not detailed in this summary.
- Review the company's Form 20-F for the full list of risk factors referenced in the forward-looking statements.
- Monitor subsequent filings for any updates on shareholder voting results or corporate actions.